-+ 0.00%
-+ 0.00%
-+ 0.00%

Goldman Sachs Maintains Buy on Merck & Co, Raises Price Target to $160

Benzinga·08/21/2026 17:51:02
Listen to the news
Goldman Sachs analyst Terence Flynn maintains Merck & Co (NYSE:MRK) with a Buy and raises the price target from $140 to $160.